O'Byrne Jason - Insider Non-Derivative Transactions at Vir Biotechnology, Inc. (VIR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 17, 2025, O'Byrne Jason's relationship to Vir Biotechnology, Inc. (VIR) is Officer (EVP & Chief Financial Officer), and currently has 110,701 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other VIR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

O'Byrne Jason - Insider Non-Derivative Transactions of VIR Common Stock

O'Byrne Jason - Insider Non-Derivative Transactions at VIR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 18, 2025	Sell -- (Common Stock)	6799	5.56	110701
Feb 23, 2025	Acquisition -- (Common Stock)	40000	0	115000
Nov 16, 2024	Acquisition -- (Common Stock)	75000	0	75000